https://it.marketscreener.com/quotazioni/azione/ALGERNON-PHARMACEUTICALS--58136278/attualita/Algernon-Pharmaceuticals-Inc-Fornisce-un-aggiornamento-sullo-studio-clinico-DMT-di-Fase-1-Il-farma-43017692/?utm_source=telegram&utm_medium=social&utm_campaign=share